Original Research
Published on 15 May 2024
Pharmacogenetic landscape of pain management variants among Mediterranean populations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1380613
- 1,842 views
Type at least 3 characters
551 articles
Articles
General Commentary
Published on 15 May 2024
Commentary: The pharmacogenomic landscape of an Indigenous Australian population
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373056
- 641 views
Original Research
Published on 09 May 2024
Assessing user perspectives on clinical pharmacogenomics consultation documentation: a user-centered evaluation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377132
- 844 views
Original Research
Published on 07 May 2024
Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1358567
- 1,051 views
Original Research
Published on 03 May 2024
Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389968
- 907 views
Original Research
Published on 02 May 2024
Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373007
- 2,518 views
- 2 citations
Original Research
Published on 01 May 2024
ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1360352
- 1,492 views
Review
Published on 24 Apr 2024
The pharmacoepigenetic paradigm in cancer treatment
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1381168
- 2,257 views
- 3 citations
Original Research
Published on 24 Apr 2024
Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399625
- 1,335 views
Original Research
Published on 17 Apr 2024
Identification of pivotal genes and regulatory networks associated with atherosclerotic carotid artery stenosis based on comprehensive bioinformatics analysis and machine learning
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364160
- 1,721 views
Original Research
Published on 11 Apr 2024
Do future healthcare professionals advocate for pharmacogenomics? A study on medical and health sciences undergraduate students
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377420
- 1,968 views
Original Research
Published on 10 Apr 2024
Exploring the impact of MiR-92a-3p on FOLFOX chemoresistance biomarker genes in colon cancer cell lines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376638
- 1,014 views
- 1 citation
Original Research
Published on 26 Mar 2024
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1384667
- 877 views
Original Research
Published on 22 Mar 2024
Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1332752
- 1,822 views
- 2 citations
Review
Published on 13 Mar 2024
Landscape of m6A RNA methylation regulators in liver cancer and its therapeutic implications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376005
- 1,618 views
- 1 citation
Original Research
Published on 11 Mar 2024
Development and validation of a pharmacogenomics reporting workflow based on the illumina global screening array chip
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1349203
- 2,737 views